Home›Companies›Biotech & Pharma›Healix Clinical Laboratory

Healix Clinical Laboratory LLC

Updated Oct 29, 2026·Latest SEC filing Jul 5, 2023·Suggest an edit

About Healix Clinical Laboratory

Healix Clinical Laboratory is a private company based in Bellaire, Texas, incorporated in 2023 in Delaware. It has reported $2,000,000 raised in one offering on Form D since July 2023. Its chief executive is Peter Bryant-Greenwood.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 5, 2023Jul 5, 2023$2,000,000of $2.7M target11$181KConvertible DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Healix Clinical Laboratory's Form D filed Jul 5, 2023.

EH
MM
Marc Mintz
Director
KR
Kevin Rosenblatt
Executive officer and director
PG
Peter Bryant-Greenwood
Chief Executive Officer and director
SS
Shea Spruill
Executive officer and director

Sources

  1. SECHealix Clinical Laboratory LLC filing history